High expression of TSP50 as well as other clinicopathological variables (histological type, TNM stage, and lymph node metastases), which were significantly correlated with TSP50 expression, was included in the multivariate analysis. Here, PRSS50 is linked to metastatic malignant neoplasm in the lymph nodes.